|
Currently, Andrew C. von Eschenbach occupies the position of President for Samaritan Health Initiatives, Inc.
He is also on the board of 15 other companies.
In the past he held the position of Director-FDA Project at Manhattan Institute For Policy Research, Inc., Director-National Cancer Institute at National Institutes of Health, Commissioner at US Food & Drug Administration, Principal at The University of Texas at Austin and Chairman-Urology Department at The University of Texas M.D. Anderson Cancer Center.
Dr. Von Eschenbach received an undergraduate degree from St. Joseph's University and a doctorate from Georgetown University School of Medicine.
|
Current positions of Andrew C. von Eschenbach | |
|
Name | Title |
Since |
Bausch + Lomb Corporation (Medical Equipment, Supplies & Distribution) |
Independent Director |
- | Bausch Health Companies Inc. (Pharmaceuticals) |
Independent Director |
2018 | Celularity Inc. (Biotechnology & Medical Research) |
Independent Director |
2021 | Radius Health, Inc. (Biotechnology & Medical Research) |
Independent Director |
2021 | Samaritan Health Initiatives, Inc. |
President |
2010 | Bausch & Lomb, Inc. |
Independent Director |
- | Viamet Pharmaceuticals, Inc. |
Director |
2011 | Viamet Pharmaceuticals Corp. |
Independent Director |
2011 | Innocrin Pharmaceuticals Holdings LLC |
Director |
- | Banyan Biomarkers, Inc. |
Director |
- | Focused Ultrasound Foundation |
Director |
2010 | Reagan-udall Foundation |
Director |
2018 | National Comprehensive Cancer Network Foundation |
Director |
- | Innocrin Pharmaceuticals, Inc. |
Director |
- | Wren Therapeutics Ltd. |
Director |
2019 | Celularity, Inc. (United States) |
Director |
2018 |
|
Holdings of Andrew C. von Eschenbach | |
|
Name | Equities | % | Valuation |
Celularity Inc. (CELU) (Biotechnology & Medical Research) | 100,000 | 0.073% | 1,169,000 USD |
Bausch + Lomb Corporation (BLCO) (Medical Equipment, Supplies & Distribution) | 12,500 | 0.0036% | 245,000 USD |
Bausch Health Companies Inc. (BHC) (Pharmaceuticals) | 8,500 | 0.0024% | 161,585 USD |
Radius Health, Inc. (RDUS) (Biotechnology & Medical Research) | 5,500 | 0.012% | 37,620 USD |
|
Andrew C. von Eschenbach: Personal Network | |
|
Name | Linked companies |
S. Edward Torres | Viamet Pharmaceuticals Corp. Viamet Pharmaceuticals, Inc. Innocrin Pharmaceuticals, Inc. Innocrin Pharmaceuticals Holdings LLC |
Douglas W. Reed | Viamet Pharmaceuticals Corp. Viamet Pharmaceuticals, Inc. Innocrin Pharmaceuticals, Inc. Innocrin Pharmaceuticals Holdings LLC |
John Alfred Paulson | Bausch + Lomb Corporation Bausch Health Companies Inc. Bausch & Lomb, Inc. |
Sarah B. Kavanagh | Bausch + Lomb Corporation Bausch Health Companies Inc. Bausch & Lomb, Inc. |
Thomas Warren Ross | Bausch + Lomb Corporation Bausch Health Companies Inc. Bausch & Lomb, Inc. |
Russel Robertson | Bausch + Lomb Corporation Bausch Health Companies Inc. Bausch & Lomb, Inc. |
Richard de Schutter | Bausch + Lomb Corporation Bausch Health Companies Inc. Bausch & Lomb, Inc. |
Joseph Papa | Bausch + Lomb Corporation Bausch Health Companies Inc. Bausch & Lomb, Inc. |
Robert J. Schotzinger | Viamet Pharmaceuticals Corp. Viamet Pharmaceuticals, Inc. Innocrin Pharmaceuticals, Inc. Innocrin Pharmaceuticals Holdings LLC |
Christina Maria Ackermann | Bausch + Lomb Corporation Bausch Health Companies Inc. |
|
© 2022 People and Ownership :
|
Andrew C. von Eschenbach : Connections | |
|
|
|